APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance Solutions

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmacovigilance Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026195 pages

Choose your research edition.

Industry ResearchPharmacovigilance Solutions Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance Solutions Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance Solutions Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance Solutions Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmacovigilance Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmacovigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmacovigilance Solutions include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmacovigilance Solutions market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacovigilance Solutions and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacovigilance Solutions revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacovigilance Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmacovigilance Solutions Segment by Company

Eurofins Scientific

Accenture

PPD

SGS

WuXi AppTec

Cognizant

ICON

IQVIA

Parexel

United BioSource

Vial

Wipro

PrimeVigilance

Aixial Group

TransPerfect

ProPharma

HCLTech

QbD Group

Quanticate

Qinecsa Solutions

Veristat

Veeda

Tigermed

Clarivate

Pharmacovigilance Solutions Segment by Type

Writing and Submitting Documents and Reports

Security Database System Services and Data Management

Signal Detection and Evaluation

Training and Consulting

Other

Pharmacovigilance Solutions Segment by Application

Preclinical

Clinical Phase

Post-launch

Pharmacovigilance Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacovigilance Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance Solutions industry.

Chapter 3: Detailed analysis of Pharmacovigilance Solutions companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance Solutionsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacovigilance Solutions Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Writing and Submitting Documents and Reports Table 3. Key Players of Security Database System Services and Data Management Table 4. Key Players of Signal Detection and Evaluation Table 3. Key Players of Training and Consulting Table 4. Key Players of Other Table 5. Global Pharmacovigilance Solutions Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Preclinical Table 7. Key Players of Clinical Phase Table 8. Key Players of Post-launch Table 9. Global Pharmacovigilance Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pharmacovigilance Solutions Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pharmacovigilance Solutions Market Share by Region (2021-2026) Table 12. Global Pharmacovigilance Solutions Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pharmacovigilance Solutions Market Share by Region (2027-2032) Table 14. Pharmacovigilance Solutions Industry Trends Table 15. Pharmacovigilance Solutions Industry Drivers Table 16. Pharmacovigilance Solutions Industry Opportunities and Challenges Table 17. Pharmacovigilance Solutions Industry Restraints Table 18. Global Pharmacovigilance Solutions Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pharmacovigilance Solutions Revenue Market Share by Company (2021-2026) Table 20. Global Pharmacovigilance Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmacovigilance Solutions Key Company Head Office and Area Served Table 22. Global Pharmacovigilance Solutions Company, Product Type & Application Table 23. Global Pharmacovigilance Solutions Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmacovigilance Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pharmacovigilance Solutions Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pharmacovigilance Solutions Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pharmacovigilance Solutions Revenue Market Share by Type (2021-2026) Table 30. Global Pharmacovigilance Solutions Revenue Market Share by Type (2027-2032) Table 31. Global Pharmacovigilance Solutions Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pharmacovigilance Solutions Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pharmacovigilance Solutions Revenue Market Share by Application (2021-2026) Table 35. Global Pharmacovigilance Solutions Revenue Market Share by Application (2027-2032) Table 36. Eurofins Scientific Company Information Table 37. Eurofins Scientific Business Overview Table 38. Eurofins Scientific Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins Scientific Pharmacovigilance Solutions Product Portfolio Table 40. Eurofins Scientific Recent Development Table 41. Accenture Company Information Table 42. Accenture Business Overview Table 43. Accenture Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Accenture Pharmacovigilance Solutions Product Portfolio Table 45. Accenture Recent Development Table 46. PPD Company Information Table 47. PPD Business Overview Table 48. PPD Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. PPD Pharmacovigilance Solutions Product Portfolio Table 50. PPD Recent Development Table 51. SGS Company Information Table 52. SGS Business Overview Table 53. SGS Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. SGS Pharmacovigilance Solutions Product Portfolio Table 55. SGS Recent Development Table 56. WuXi AppTec Company Information Table 57. WuXi AppTec Business Overview Table 58. WuXi AppTec Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. WuXi AppTec Pharmacovigilance Solutions Product Portfolio Table 60. WuXi AppTec Recent Development Table 61. Cognizant Company Information Table 62. Cognizant Business Overview Table 63. Cognizant Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Cognizant Pharmacovigilance Solutions Product Portfolio Table 65. Cognizant Recent Development Table 66. ICON Company Information Table 67. ICON Business Overview Table 68. ICON Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ICON Pharmacovigilance Solutions Product Portfolio Table 70. ICON Recent Development Table 71. IQVIA Company Information Table 72. IQVIA Business Overview Table 73. IQVIA Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. IQVIA Pharmacovigilance Solutions Product Portfolio Table 75. IQVIA Recent Development Table 76. Parexel Company Information Table 77. Parexel Business Overview Table 78. Parexel Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Parexel Pharmacovigilance Solutions Product Portfolio Table 80. Parexel Recent Development Table 81. United BioSource Company Information Table 82. United BioSource Business Overview Table 83. United BioSource Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. United BioSource Pharmacovigilance Solutions Product Portfolio Table 85. United BioSource Recent Development Table 86. Vial Company Information Table 87. Vial Business Overview Table 88. Vial Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Vial Pharmacovigilance Solutions Product Portfolio Table 90. Vial Recent Development Table 91. Wipro Company Information Table 92. Wipro Business Overview Table 93. Wipro Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Wipro Pharmacovigilance Solutions Product Portfolio Table 95. Wipro Recent Development Table 96. PrimeVigilance Company Information Table 97. PrimeVigilance Business Overview Table 98. PrimeVigilance Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. PrimeVigilance Pharmacovigilance Solutions Product Portfolio Table 100. PrimeVigilance Recent Development Table 101. Aixial Group Company Information Table 102. Aixial Group Business Overview Table 103. Aixial Group Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Aixial Group Pharmacovigilance Solutions Product Portfolio Table 105. Aixial Group Recent Development Table 106. TransPerfect Company Information Table 107. TransPerfect Business Overview Table 108. TransPerfect Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. TransPerfect Pharmacovigilance Solutions Product Portfolio Table 110. TransPerfect Recent Development Table 111. ProPharma Company Information Table 112. ProPharma Business Overview Table 113. ProPharma Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. ProPharma Pharmacovigilance Solutions Product Portfolio Table 115. ProPharma Recent Development Table 116. HCLTech Company Information Table 117. HCLTech Business Overview Table 118. HCLTech Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. HCLTech Pharmacovigilance Solutions Product Portfolio Table 120. HCLTech Recent Development Table 121. QbD Group Company Information Table 122. QbD Group Business Overview Table 123. QbD Group Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. QbD Group Pharmacovigilance Solutions Product Portfolio Table 125. QbD Group Recent Development Table 126. Quanticate Company Information Table 127. Quanticate Business Overview Table 128. Quanticate Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Quanticate Pharmacovigilance Solutions Product Portfolio Table 130. Quanticate Recent Development Table 131. Qinecsa Solutions Company Information Table 132. Qinecsa Solutions Business Overview Table 133. Qinecsa Solutions Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio Table 135. Qinecsa Solutions Recent Development Table 136. Veristat Company Information Table 137. Veristat Business Overview Table 138. Veristat Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Veristat Pharmacovigilance Solutions Product Portfolio Table 140. Veristat Recent Development Table 141. Veeda Company Information Table 142. Veeda Business Overview Table 143. Veeda Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. Veeda Pharmacovigilance Solutions Product Portfolio Table 145. Veeda Recent Development Table 146. Tigermed Company Information Table 147. Tigermed Business Overview Table 148. Tigermed Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. Tigermed Pharmacovigilance Solutions Product Portfolio Table 150. Tigermed Recent Development Table 151. Clarivate Company Information Table 152. Clarivate Business Overview Table 153. Clarivate Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 154. Clarivate Pharmacovigilance Solutions Product Portfolio Table 155. Clarivate Recent Development Table 156. North America Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million) Table 157. North America Pharmacovigilance Solutions Market Size by Type (2027-2032) & (US$ Million) Table 158. North America Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million) Table 159. North America Pharmacovigilance Solutions Market Size by Application (2027-2032) & (US$ Million) Table 160. North America Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Pharmacovigilance Solutions Market Size by Country (2021-2026) Table 162. North America Pharmacovigilance Solutions Market Size by Country (2027-2032) Table 163. Europe Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million) Table 164. Europe Pharmacovigilance Solutions Market Size by Type (2027-2032) & (US$ Million) Table 165. Europe Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million) Table 166. Europe Pharmacovigilance Solutions Market Size by Application (2027-2032) & (US$ Million) Table 167. Europe Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Pharmacovigilance Solutions Market Size by Country (2021-2026) Table 169. Europe Pharmacovigilance Solutions Market Size by Country (2027-2032) Table 170. China Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million) Table 171. China Pharmacovigilance Solutions Market Size by Type (2027-2032) & (US$ Million) Table 172. China Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million) Table 173. China Pharmacovigilance Solutions Market Size by Application (2027-2032) & (US$ Million) Table 174. Asia Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million) Table 175. Asia Pharmacovigilance Solutions Market Size by Type (2027-2032) & (US$ Million) Table 176. Asia Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million) Table 177. Asia Pharmacovigilance Solutions Market Size by Application (2027-2032) & (US$ Million) Table 178. Asia Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Pharmacovigilance Solutions Market Size by Country (2021-2026) Table 180. Asia Pharmacovigilance Solutions Market Size by Country (2027-2032) Table 181. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million) Table 182. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Type (2027-2032) & (US$ Million) Table 183. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million) Table 184. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Application (2027-2032) & (US$ Million) Table 185. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021-2026) Table 187. South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Pharmacovigilance Solutions Product Image Figure 2. Global Pharmacovigilance Solutions Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmacovigilance Solutions Market Share by Type: 2025 VS 2032 Figure 4. Writing and Submitting Documents and Reports Image Figure 5. Security Database System Services and Data Management Image Figure 6. Signal Detection and Evaluation Image Figure 7. Training and Consulting Image Figure 8. Other Image Figure 9. Global Pharmacovigilance Solutions Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Pharmacovigilance Solutions Market Share by Application: 2025 VS 2032 Figure 11. Preclinical Image Figure 12. Clinical Phase Image Figure 13. Post-launch Image Figure 14. Global Pharmacovigilance Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 16. Global Pharmacovigilance Solutions Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Pharmacovigilance Solutions Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Pharmacovigilance Solutions Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pharmacovigilance Solutions Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmacovigilance Solutions Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmacovigilance Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmacovigilance Solutions Revenue Market Share by Application (2021-2032) Figure 25. North America Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 26. North America Pharmacovigilance Solutions Market Share by Type (2021-2032) Figure 27. North America Pharmacovigilance Solutions Market Share by Application (2021-2032) Figure 28. North America Pharmacovigilance Solutions Market Share by Country (2021-2032) Figure 29. United States Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 30. Canada Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmacovigilance Solutions Market Share by Type (2021-2032) Figure 34. Europe Pharmacovigilance Solutions Market Share by Application (2021-2032) Figure 35. Europe Pharmacovigilance Solutions Market Share by Country (2021-2032) Figure 36. Germany Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 37. France Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 39. Italy Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 40. Russia Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmacovigilance Solutions Market Share by Type (2021-2032) Figure 44. China Pharmacovigilance Solutions Market Share by Application (2021-2032) Figure 45. Asia Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 46. Asia Pharmacovigilance Solutions Market Share by Type (2021-2032) Figure 47. Asia Pharmacovigilance Solutions Market Share by Application (2021-2032) Figure 48. Asia Pharmacovigilance Solutions Market Share by Country (2021-2032) Figure 49. Japan Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 53. India Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 54. Australia Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmacovigilance Solutions Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Pharmacovigilance Solutions Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Pharmacovigilance Solutions Market Share by Country (2021-2032) Figure 59. Brazil Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 64. UAE Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 66. Chile Pharmacovigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Writing and Submitting Documents and Reports
  • Security Database System Services and Data Management
  • Signal Detection and Evaluation
  • Training and Consulting
  • Other
Applications
  • Preclinical
  • Clinical Phase
  • Post-launch
Companies covered
  • Eurofins Scientific
  • Accenture
  • PPD
  • SGS
  • WuXi AppTec
  • Cognizant
  • ICON
  • IQVIA
  • Parexel
  • United BioSource
  • Vial
  • Wipro
  • PrimeVigilance
  • Aixial Group
  • TransPerfect
  • ProPharma
  • HCLTech
  • QbD Group
  • Quanticate
  • Qinecsa Solutions
  • Veristat
  • Veeda
  • Tigermed
  • Clarivate

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmacovigilance Solutions Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Writing and Submitting Documents and Reports
  5. 1.2.3 Security Database System Services and Data Management
  6. 1.2.4 Signal Detection and Evaluation
  7. 1.2.5 Training and Consulting
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Pharmacovigilance Solutions Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Preclinical
  12. 1.3.3 Clinical Phase
  13. 1.3.4 Post-launch
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Pharmacovigilance Solutions Growth Trends by Region
  16. 1.5.1 Global Pharmacovigilance Solutions Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Pharmacovigilance Solutions Market Size by Region (2021-2026)
  18. 1.5.3 Pharmacovigilance Solutions Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Pharmacovigilance Solutions Market Dynamics
  1. 2.1 Pharmacovigilance Solutions Industry Trends
  2. 2.2 Pharmacovigilance Solutions Industry Drivers
  3. 2.3 Pharmacovigilance Solutions Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance Solutions Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmacovigilance Solutions Revenue by Company (2021-2026)
  2. 3.2 Global Pharmacovigilance Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmacovigilance Solutions Key Company Head office and Area Served
  4. 3.4 Global Pharmacovigilance Solutions Company, Product Type & Application
  5. 3.5 Global Pharmacovigilance Solutions Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmacovigilance Solutions Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmacovigilance Solutions Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmacovigilance Solutions Tier 1, Tier 2, and Tier 3
4 Pharmacovigilance Solutions Market by Type
  1. 4.1 Global Pharmacovigilance Solutions Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmacovigilance Solutions Market Size by Type (2021-2032)
  3. 4.3 Global Pharmacovigilance Solutions Market Size Share by Type (2021-2032)
5 Pharmacovigilance Solutions Market by Application
  1. 5.1 Global Pharmacovigilance Solutions Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacovigilance Solutions Market Size by Application (2021-2032)
  3. 5.3 Global Pharmacovigilance Solutions Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins Scientific
  2. 6.1.1 Eurofins Scientific Company Information
  3. 6.1.2 Eurofins Scientific Business Overview
  4. 6.1.3 Eurofins Scientific Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Scientific Pharmacovigilance Solutions Product Portfolio
  6. 6.1.5 Eurofins Scientific Recent Developments
  7. 6.2 Accenture
  8. 6.2.1 Accenture Company Information
  9. 6.2.2 Accenture Business Overview
  10. 6.2.3 Accenture Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Accenture Pharmacovigilance Solutions Product Portfolio
  12. 6.2.5 Accenture Recent Developments
  13. 6.3 PPD
  14. 6.3.1 PPD Company Information
  15. 6.3.2 PPD Business Overview
  16. 6.3.3 PPD Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 PPD Pharmacovigilance Solutions Product Portfolio
  18. 6.3.5 PPD Recent Developments
  19. 6.4 SGS
  20. 6.4.1 SGS Company Information
  21. 6.4.2 SGS Business Overview
  22. 6.4.3 SGS Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 SGS Pharmacovigilance Solutions Product Portfolio
  24. 6.4.5 SGS Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi AppTec Pharmacovigilance Solutions Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Cognizant
  32. 6.6.1 Cognizant Company Information
  33. 6.6.2 Cognizant Business Overview
  34. 6.6.3 Cognizant Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cognizant Pharmacovigilance Solutions Product Portfolio
  36. 6.6.5 Cognizant Recent Developments
  37. 6.7 ICON
  38. 6.7.1 ICON Company Information
  39. 6.7.2 ICON Business Overview
  40. 6.7.3 ICON Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ICON Pharmacovigilance Solutions Product Portfolio
  42. 6.7.5 ICON Recent Developments
  43. 6.8 IQVIA
  44. 6.8.1 IQVIA Company Information
  45. 6.8.2 IQVIA Business Overview
  46. 6.8.3 IQVIA Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 IQVIA Pharmacovigilance Solutions Product Portfolio
  48. 6.8.5 IQVIA Recent Developments
  49. 6.9 Parexel
  50. 6.9.1 Parexel Company Information
  51. 6.9.2 Parexel Business Overview
  52. 6.9.3 Parexel Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Parexel Pharmacovigilance Solutions Product Portfolio
  54. 6.9.5 Parexel Recent Developments
  55. 6.10 United BioSource
  56. 6.10.1 United BioSource Company Information
  57. 6.10.2 United BioSource Business Overview
  58. 6.10.3 United BioSource Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 United BioSource Pharmacovigilance Solutions Product Portfolio
  60. 6.10.5 United BioSource Recent Developments
  61. 6.11 Vial
  62. 6.11.1 Vial Company Information
  63. 6.11.2 Vial Business Overview
  64. 6.11.3 Vial Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Vial Pharmacovigilance Solutions Product Portfolio
  66. 6.11.5 Vial Recent Developments
  67. 6.12 Wipro
  68. 6.12.1 Wipro Company Information
  69. 6.12.2 Wipro Business Overview
  70. 6.12.3 Wipro Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Wipro Pharmacovigilance Solutions Product Portfolio
  72. 6.12.5 Wipro Recent Developments
  73. 6.13 PrimeVigilance
  74. 6.13.1 PrimeVigilance Company Information
  75. 6.13.2 PrimeVigilance Business Overview
  76. 6.13.3 PrimeVigilance Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 PrimeVigilance Pharmacovigilance Solutions Product Portfolio
  78. 6.13.5 PrimeVigilance Recent Developments
  79. 6.14 Aixial Group
  80. 6.14.1 Aixial Group Company Information
  81. 6.14.2 Aixial Group Business Overview
  82. 6.14.3 Aixial Group Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Aixial Group Pharmacovigilance Solutions Product Portfolio
  84. 6.14.5 Aixial Group Recent Developments
  85. 6.15 TransPerfect
  86. 6.15.1 TransPerfect Company Information
  87. 6.15.2 TransPerfect Business Overview
  88. 6.15.3 TransPerfect Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 TransPerfect Pharmacovigilance Solutions Product Portfolio
  90. 6.15.5 TransPerfect Recent Developments
  91. 6.16 ProPharma
  92. 6.16.1 ProPharma Company Information
  93. 6.16.2 ProPharma Business Overview
  94. 6.16.3 ProPharma Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 ProPharma Pharmacovigilance Solutions Product Portfolio
  96. 6.16.5 ProPharma Recent Developments
  97. 6.17 HCLTech
  98. 6.17.1 HCLTech Company Information
  99. 6.17.2 HCLTech Business Overview
  100. 6.17.3 HCLTech Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 HCLTech Pharmacovigilance Solutions Product Portfolio
  102. 6.17.5 HCLTech Recent Developments
  103. 6.18 QbD Group
  104. 6.18.1 QbD Group Company Information
  105. 6.18.2 QbD Group Business Overview
  106. 6.18.3 QbD Group Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 QbD Group Pharmacovigilance Solutions Product Portfolio
  108. 6.18.5 QbD Group Recent Developments
  109. 6.19 Quanticate
  110. 6.19.1 Quanticate Company Information
  111. 6.19.2 Quanticate Business Overview
  112. 6.19.3 Quanticate Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Quanticate Pharmacovigilance Solutions Product Portfolio
  114. 6.19.5 Quanticate Recent Developments
  115. 6.20 Qinecsa Solutions
  116. 6.20.1 Qinecsa Solutions Company Information
  117. 6.20.2 Qinecsa Solutions Business Overview
  118. 6.20.3 Qinecsa Solutions Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio
  120. 6.20.5 Qinecsa Solutions Recent Developments
  121. 6.21 Veristat
  122. 6.21.1 Veristat Company Information
  123. 6.21.2 Veristat Business Overview
  124. 6.21.3 Veristat Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Veristat Pharmacovigilance Solutions Product Portfolio
  126. 6.21.5 Veristat Recent Developments
  127. 6.22 Veeda
  128. 6.22.1 Veeda Company Information
  129. 6.22.2 Veeda Business Overview
  130. 6.22.3 Veeda Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Veeda Pharmacovigilance Solutions Product Portfolio
  132. 6.22.5 Veeda Recent Developments
  133. 6.23 Tigermed
  134. 6.23.1 Tigermed Company Information
  135. 6.23.2 Tigermed Business Overview
  136. 6.23.3 Tigermed Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Tigermed Pharmacovigilance Solutions Product Portfolio
  138. 6.23.5 Tigermed Recent Developments
  139. 6.24 Clarivate
  140. 6.24.1 Clarivate Company Information
  141. 6.24.2 Clarivate Business Overview
  142. 6.24.3 Clarivate Pharmacovigilance Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Clarivate Pharmacovigilance Solutions Product Portfolio
  144. 6.24.5 Clarivate Recent Developments
7 North America
  1. 7.1 North America Pharmacovigilance Solutions Market Size (2021-2032)
  2. 7.2 North America Pharmacovigilance Solutions Market Size by Type
  3. 7.2.1 North America Pharmacovigilance Solutions Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmacovigilance Solutions Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmacovigilance Solutions Market Share by Type (2021-2032)
  6. 7.3 North America Pharmacovigilance Solutions Market Size by Application
  7. 7.3.1 North America Pharmacovigilance Solutions Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmacovigilance Solutions Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmacovigilance Solutions Market Share by Application (2021-2032)
  10. 7.4 North America Pharmacovigilance Solutions Market Size by Country
  11. 7.4.1 North America Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmacovigilance Solutions Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmacovigilance Solutions Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmacovigilance Solutions Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmacovigilance Solutions Market Size (2021-2032)
  2. 8.2 Europe Pharmacovigilance Solutions Market Size by Type
  3. 8.2.1 Europe Pharmacovigilance Solutions Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmacovigilance Solutions Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmacovigilance Solutions Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmacovigilance Solutions Market Size by Application
  7. 8.3.1 Europe Pharmacovigilance Solutions Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmacovigilance Solutions Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmacovigilance Solutions Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmacovigilance Solutions Market Size by Country
  11. 8.4.1 Europe Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmacovigilance Solutions Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmacovigilance Solutions Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmacovigilance Solutions Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmacovigilance Solutions Market Size (2021-2032)
  2. 9.2 China Pharmacovigilance Solutions Market Size by Type
  3. 9.2.1 China Pharmacovigilance Solutions Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmacovigilance Solutions Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmacovigilance Solutions Market Share by Type (2021-2032)
  6. 9.3 China Pharmacovigilance Solutions Market Size by Application
  7. 9.3.1 China Pharmacovigilance Solutions Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmacovigilance Solutions Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmacovigilance Solutions Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmacovigilance Solutions Market Size (2021-2032)
  2. 10.2 Asia Pharmacovigilance Solutions Market Size by Type
  3. 10.2.1 Asia Pharmacovigilance Solutions Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmacovigilance Solutions Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmacovigilance Solutions Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmacovigilance Solutions Market Size by Application
  7. 10.3.1 Asia Pharmacovigilance Solutions Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmacovigilance Solutions Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmacovigilance Solutions Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmacovigilance Solutions Market Size by Country
  11. 10.4.1 Asia Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmacovigilance Solutions Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmacovigilance Solutions Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmacovigilance Solutions Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmacovigilance Solutions Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmacovigilance Solutions Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmacovigilance Solutions Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmacovigilance Solutions Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst